HLB Decides to Absorb and Merge HLB Saengmyeong Science
HLB announced on the 1st that it has decided to merge with HLB Life Science through an absorption-type merger. The surviving company will be HLB, and the absorbed company, HLB Life Science, will be dissolved. The merger ratio between the merging company and the absorbed company is 1 to 0.1167458, and the number of new shares issued for the merger is 11,806,507.
Hot Picks Today
"Stock Set to Double: This Company Smiles Every...
- "Is Yours Just Gathering Dust at Home? Millennials & Gen Z Rediscover Digicams O...
- "Continuous Groundwater Pumping Causes Mexico City to Sink 24cm Annually... 'Gia...
- "I Take Full Responsibility"... Seongjae Ahn Issues Direct Apology for 'Wine Swi...
- “She Shouted, ‘The Rope Isn’t Tied!’... Chinese Woman Falls from 168m Cliff ...
The merger date is set for August 1. The company explained the purpose of the merger as “maximizing human and technological synergy through management efficiency by simplifying the governance structure and integrating new drug development and healthcare businesses.”
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.